Avantor (AVTR) Shares Outstanding (Diluted Average) (2018 - 2026)
Avantor (AVTR) recorded quarterly Shares Outstanding (Diluted Average) of $676.8 million in Q1 2026, down 0.56% quarter-over-quarter from $680.6 million in Q4 2025, and down 0.82% on a YoY basis from $682.4 million in Q1 2025.
Avantor (AVTR) Shares Outstanding (Diluted Average) (2018 - 2026) Analysis & Trends
Avantor's Shares Outstanding (Diluted Average) history runs 9 years deep, the most recent figure standing at $676.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) fell 0.82% year-over-year to $676.8 million; the TTM figure through Mar 2026 stood at $676.8 million (down 0.82% YoY), while the FY2025 annual figure was $680.6 million, changed 0.19% from the prior year.
- Shares Outstanding (Diluted Average) was $676.8 million for Q1 2026 at Avantor, down from $680.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $683.0 million in Q3 2024 to a low of $676.8 million in Q1 2026.
- Historically, Shares Outstanding (Diluted Average) has averaged $680.3 million across 5 years, with a median of $680.6 million in 2025.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Diluted Average) increased 15.65% in 2022, then fell 0.82% in 2026.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $679.4 million in 2022, then declined by 0.15% to $678.4 million in 2023, then advanced by 0.52% to $681.9 million in 2024, then fell by 0.19% to $680.6 million in 2025, then decreased by 0.56% to $676.8 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $676.8 million (Q1 2026), $680.6 million (Q4 2025), and $681.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Avantor | 6.47 Bn | 6.19 Bn | 500.70 Mn | 676.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 676.80 Mn |
| Dec 31, 2025 | 680.60 Mn |
| Sep 30, 2025 | 681.40 Mn |
| Jun 30, 2025 | 682.00 Mn |
| Mar 31, 2025 | 682.40 Mn |
| Dec 31, 2024 | 681.90 Mn |
| Sep 30, 2024 | 683.00 Mn |
| Jun 30, 2024 | 682.60 Mn |
| Mar 31, 2024 | 681.40 Mn |
| Dec 31, 2023 | 678.40 Mn |
| Sep 30, 2023 | 678.50 Mn |
| Jun 30, 2023 | 677.90 Mn |
| Mar 31, 2023 | 678.10 Mn |
| Dec 31, 2022 | 679.40 Mn |
| Sep 30, 2022 | 679.30 Mn |
| Jun 30, 2022 | 680.20 Mn |
| Mar 31, 2022 | 681.30 Mn |
| Dec 31, 2021 | 599.60 Mn |
| Sep 30, 2021 | 598.10 Mn |
| Jun 30, 2021 | 591.10 Mn |